FI883997A - Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi Download PDF

Info

Publication number
FI883997A
FI883997A FI883997A FI883997A FI883997A FI 883997 A FI883997 A FI 883997A FI 883997 A FI883997 A FI 883997A FI 883997 A FI883997 A FI 883997A FI 883997 A FI883997 A FI 883997A
Authority
FI
Finland
Prior art keywords
phenyl
preparation
therapeutically useful
quinolinecarboxylic acids
useful substituted
Prior art date
Application number
FI883997A
Other languages
English (en)
Swedish (sv)
Other versions
FI92692C (fi
FI883997A0 (fi
FI92692B (fi
Inventor
Leslie H Sutherland
Adolph E Sloboda
Ralph Grassing Child
John F Poletto
Dennis W Powell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI883997A0 publication Critical patent/FI883997A0/fi
Publication of FI883997A publication Critical patent/FI883997A/fi
Application granted granted Critical
Publication of FI92692B publication Critical patent/FI92692B/fi
Publication of FI92692C publication Critical patent/FI92692C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI883997A 1987-08-31 1988-08-30 Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi FI92692C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/090,996 US4847381A (en) 1987-08-31 1987-08-31 2-Phenyl-4-quinoline carboxylic acids
US9099687 1987-08-31

Publications (4)

Publication Number Publication Date
FI883997A0 FI883997A0 (fi) 1988-08-30
FI883997A true FI883997A (fi) 1989-03-01
FI92692B FI92692B (fi) 1994-09-15
FI92692C FI92692C (fi) 1994-12-27

Family

ID=22225261

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883997A FI92692C (fi) 1987-08-31 1988-08-30 Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi

Country Status (24)

Country Link
US (1) US4847381A (fi)
EP (1) EP0305952B1 (fi)
JP (1) JP2760379B2 (fi)
KR (1) KR970005909B1 (fi)
AR (1) AR245698A1 (fi)
AT (1) ATE90079T1 (fi)
AU (1) AU613661B2 (fi)
CA (1) CA1333606C (fi)
CS (1) CS274434B2 (fi)
DD (1) DD282225A5 (fi)
DE (1) DE3881456T2 (fi)
DK (1) DK169473B1 (fi)
ES (1) ES2058191T3 (fi)
FI (1) FI92692C (fi)
GR (1) GR3008033T3 (fi)
HU (1) HU202498B (fi)
IE (1) IE65148B1 (fi)
IL (1) IL87457A (fi)
NO (1) NO174961C (fi)
NZ (1) NZ225924A (fi)
PH (1) PH26258A (fi)
PL (1) PL156232B1 (fi)
PT (1) PT88365B (fi)
ZA (1) ZA886443B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US4918077A (en) * 1989-01-25 1990-04-17 E. I. Du Pont De Nemours & Co., Inc. 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
JP2002505689A (ja) 1997-06-19 2002-02-19 セプレイコー インコーポレイテッド キノリン−インドール抗菌剤、それらに関する用途及び組成物
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
SE9901366D0 (sv) * 1999-04-16 1999-04-16 Pharmacia & Upjohn Ab Injector device and method for its operation
US20020121638A1 (en) * 2000-06-30 2002-09-05 Vladimir Grushin Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
WO2009016812A1 (ja) * 2007-07-27 2009-02-05 Kowa Company, Ltd. ２－フェニルキノリン－４－カルボン酸誘導体を有効成分とする貧血の予防及び／又は治療剤
JP2016537360A (ja) 2013-11-22 2016-12-01 ジェンザイム・コーポレーション 神経変性疾患を治療するための新規な方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776290A (en) * 1957-01-01 Hydroxy cevchoninates and carboxylic
US2008923A (en) * 1931-07-09 1935-07-23 Graham Patmore L Cinchoninic acid salts of piperazines
US2077903A (en) * 1933-12-15 1937-04-20 Gen Aniline Works Inc Process of preparing 3-amino-quinolines
US2486440A (en) * 1946-01-10 1949-11-01 Gen Aniline & Film Corp Production of phenazonium dyestuff images
BE502610A (fi) * 1950-04-18
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds
DE1049701B (fi) * 1957-02-21
FR6592M (fi) * 1967-10-31 1968-12-30
BE794945A (fr) * 1972-02-04 1973-08-02 Sandoz Sa Application de derives de la quinoleine pour stabiliser des matieres organiques contre les effets de la lumiere ultraviolette
US4009020A (en) * 1975-05-06 1977-02-22 Amchem Products, Inc. Method of regulating plant growth
SU1109402A1 (ru) * 1982-10-12 1984-08-23 Предприятие П/Я Р-6496 Способ получени производных 2-(хинолил-4)-5-арилоксазола
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
ZA845594B (en) * 1983-07-22 1986-03-26 Du Pont Phenylquinolinecarboxylic acids and derivatives as antitumor agents

Also Published As

Publication number Publication date
AU613661B2 (en) 1991-08-08
KR970005909B1 (ko) 1997-04-22
CS274434B2 (en) 1991-04-11
US4847381A (en) 1989-07-11
FI92692C (fi) 1994-12-27
DK482688D0 (da) 1988-08-30
PT88365B (pt) 1995-03-31
FI883997A0 (fi) 1988-08-30
ZA886443B (en) 1989-04-26
HUT48597A (en) 1989-06-28
NO883865L (no) 1989-03-01
JP2760379B2 (ja) 1998-05-28
EP0305952A1 (en) 1989-03-08
CS587588A2 (en) 1990-06-13
IL87457A (en) 1994-08-26
DE3881456T2 (de) 1994-01-13
AU2167888A (en) 1989-03-02
FI92692B (fi) 1994-09-15
DK169473B1 (da) 1994-11-07
NZ225924A (en) 1991-07-26
PL274471A1 (en) 1989-05-02
KR890003703A (ko) 1989-04-17
NO174961B (no) 1994-05-02
GR3008033T3 (fi) 1993-09-30
EP0305952B1 (en) 1993-06-02
PL156232B1 (en) 1992-02-28
PH26258A (en) 1992-04-01
NO174961C (no) 1994-08-10
IL87457A0 (en) 1989-01-31
DK482688A (da) 1989-03-01
PT88365A (pt) 1989-06-30
ATE90079T1 (de) 1993-06-15
JPH01110673A (ja) 1989-04-27
NO883865D0 (no) 1988-08-30
IE65148B1 (en) 1995-10-04
IE882628L (en) 1989-02-28
HU202498B (en) 1991-03-28
ES2058191T3 (es) 1994-11-01
CA1333606C (en) 1994-12-20
AR245698A1 (es) 1994-02-28
DD282225A5 (de) 1990-09-05
DE3881456D1 (de) 1993-07-08

Similar Documents

Publication Publication Date Title
PT87754A (pt) Process for the preparation of new amino acid derivatives
PT86875A (pt) Process for the preparation of phenylcarbamate
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI881223A0 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
PT87191A (pt) Process for the preparation of nucleosides
FI883997A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI96601C (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
FI895393A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI92064C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi
FI890723A (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
FI883589A0 (fi) Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
PT88431A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: AMERICAN CYANAMID COMPANY